Year: 2008
Type: paratext
Abstract: A wave, 122, 148 ablation control system (ACS), 104 ablation of atrial fibrillation.see also surgical treatment of atrial fibrillation alternative energy sources for, 103-4 cryoablation (see cryoablation) laser (see laser ablation) microwave (see microwave ablation) radiofrequency (see radiofrequency (RF) ablation) ultrasound (see ultrasound ablation) approaches, 206-7 bi-atrial, 104, 155 characteristics of, 132-3 circumferential pulmonary vein, 206-12 coronary sinus, 77, 80-82, 108 endocardial, 81, 133-5, 145, 170-71, 176-8, 194 epicardial (see epicardial ablation) His bundle, 101, 186, 221 for maintenance of atrial fibrillation, 49, 61-2, 65, 74-80 percutaneous (see percutaneous ablation) remote-controlled, 212 risk to thoracic structures, 6 segmental ostial, 74, 206 treatment rate of, 37 ACC guidelines, 41, 44 accessory pathways, 224, 238 acetylcholine (ACh), 23, 52, 73-4 aconitine, 26, 49 acquired atrial fibrillation, 31, 33-4 acquired tachycardia, 216-17 ACS (ablation control system), 104 ACT trials, 43 action potential duration (APD) age and, 59 antiarrhythmic drugs and, 38 CHF and, 55, 57 cholinergic AF and, 52 electrical remodeling and, 23, 26-7 ion channels and, 62 monogenic disease and, 33 rapid atrial pacing (RAP) and, 54-5 action potential duration restitution (APDR) kinetics, 27-8 activation pattern, 63, 66, 74, 76 ACTIVE trial, 45 adenylcyclase, 23 ADONIS trial, 43 adrenaline, 23 adrenergic drive, increased, 25-6 AERP.see atrial effective refractory period (AERP) AF. see atrial fibrillation (AF) AFASAK trial, 44 AFCL, 80 AFF (atrial filling fraction), 117-18 AFFIRM trial, 42-3, 207 age action potential duration (APD) and, 59 alterations in ionic currents and, 55 atria in animal models of aging, 59 coronary artery disease and, 242 mini-maze procedure and, 121 pediatric patients with congenital cardiopathies, 215-29 as predictor of atrial fibrillation, 32, 51 prevalence of atrial fibrillation and, 37, 44, 59, 237 RF modified maze procedure and, 147 structural changes and, 64 AHA guidelines, 41, 44 alanine aminotransferase (ALT), 45 ALIVE study, 43 Allessie lesion line concept, 167 ALT (alanine aminotransferase), 45 alternative energy sources for atrial fibrillation characteristics of, 132-3 cryoablation (see cryoablation) laser (see laser ablation) mechanism of tissue injury, 131-2 microwave (see microwave ablation) modalities of, 135-41 radiofrequency (see radiofrequency (RF) ablation) ultrasound (see ultrasound ablation) AMADEUS trial, 45 amiodarone, 38-43, 79,
Source: Wiley eBooks
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4242913174